Displaying drugs 14851 - 14875 of 15134 in total
Fenoxazoline
Experimental
DAS869
Experimental
7-Deazaguanine
Experimental
Fazadinium bromide
Experimental
(3,4-Dihydroxy-Phenyl)-Triphenyl-Arsonium
Experimental
Immucillin-G
Experimental
CRx-401
CRx-401 is a novel insulin sensitizer designed to provide anti-diabetic activity without promoting weight gain. It consists of a low dose of the analgesic diflunisal in conjunction with a modified-release therapeutic dose of bezafibrate, an anti-cholesterol agent. In third-party clinical studies, the dose of bezafibrate contained in CRx-401 has been...
Investigational
Matched Description: … lipid profiles, and this dose has proven to be well tolerated in clinical trials. ... in CRx-401 has been observed to have a positive impact on cellular pathways that influence glycemic and …
CRA-9334
Experimental
Displaying drugs 14851 - 14875 of 15134 in total